About this trial
The study will be conducted using a randomized controlled method. Children with type 1 diabetes who are admitted to the Pediatric Endocrinology Service will be divided into two groups by randomization method. Following randomization, children in the experimental group will play a therapeutic game before their subcutaneous insulin treatment. In the subcutaneous insulin treatment of the children in the control group, the routine practice of the clinic will be applied. Anxiety and fear levels of all children in the experimental and control groups will be evaluated before and after subcutaneous insulin treatment.
Eligibility criteria
Qualifiers
The child must be between the ages of 9 and 12 (since the State Anxiety Inventory for Children Scale is for this age range)
Diagnosed with type 1 diabetes
Absence of mental retardation
Receiving subcutaneous insulin treatment for the first time
Disqualifiers
Visual, hearing or speech impairment
Illiteracy of the child
Having a clinical condition that prevents playing games (excessive fatigue, weakness, etc.)
Trial design
Treatments tested in this trial
- Therapeutic Play
Treatment groups
Locations
Sponsors and collaborators
Istanbul University - Cerrahpasa
Lead sponsor
Fenerbahce University
Sponsor institution